Evidence of a Role for Osteoprotegerin in the Pathogenesis of Pulmonary Arterial Hypertension-Reference-Cited by-同舟云学术

Evidence of a Role for Osteoprotegerin in the Pathogenesis of Pulmonary Arterial Hypertension

Published:2008-01 Issue:1 Volume:172 Page:256-264
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Lawrie Allan,Waterman Elizabeth,Southwood Mark,Evans David,Suntharalingam Jay,Francis Sheila,Crossman David,Croucher Peter,Morrell Nicholas,Newman Christopher

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference39 articles.

1. Histopathology of primary pulmonary hypertension: a qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry;Pietra;Circulation,1989

2. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension;Lane;Nat Genet,2000

3. Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension;Eddahibi;J Clin Invest,2001

4. Lipopolysaccharide and interleukin 1 augment the effects of hypoxia and inflammation in human pulmonary arterial tissue;Ziesche;Proc Natl Acad Sci USA,1996

5. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension;Humbert;Am J Respir Crit Care Med,1995

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD95 (Fas) and CD95L (FasL)-mediated non-canonical signaling pathways;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11

2. The relationship between serum osteoprotegerin levels and right atrial and ventricular speckle-tracking measurements in essential hypertension patients with normal left ventricular systolic function;CARDIOVASC J AFR;2023

3. Emerging biologics for the treatment of pulmonary arterial hypertension;Journal of Drug Targeting;2023-04-26

4. New Drugs and Therapies in Pulmonary Arterial Hypertension;International Journal of Molecular Sciences;2023-03-19

5. Inflammatory biomarkers in pulmonary arterial hypertension: ready for clinical implementation?;European Respiratory Journal;2023-03